Mapping large numbers of results may take a few moments.
Search Results
Showing 1 - 30 of 30 results found.
Company | Activity | Company Description | Location | |
---|---|---|---|---|
Company Allucent | Activity: Contract Research and Testing | Company Description Allucent provides contract research services, including preclinical and clinical study design and management, regulatory assessments, data management and statistics, CMC program management, medical writing and submission of regulatory documents. | Location Cary | |
Company Asensus Surgical Inc. | Activity: Research and Development | Company Description Asensus Surgical develops and sells instruments and robotics for laparoscopic minimally invasive surgery. | Location Durham | |
Company AskBio | Activity: Research and Development | Company Description Asklepios BioPharmaceutical (AskBio) uses adeno-associated virus (AAV) technology to develop and manufacture gene therapies for rare diseases and other genetic disorders. | Location Research Triangle Park | |
Company Astellas Gene Therapies | Activity: Production and Manufacturing | Company Description Astellas Gene Therapies manufactures AAV gene therapy products for rare diseases. | Location Sanford | |
Company AstraZeneca (Durham) | Activity: Research and Development | Company Description AstraZeneca's site in Durham develops combination therapies and formulations of inhaled drugs for chronic respiratory diseases such as asthma and COPD. | Location Durham | |
Company ATEX Technologies Inc. | Activity: Production and Manufacturing | Company Description ATEX manufactures custom engineered implantable textile components for medical devices. Components are manufactured using weaving, knitting, braiding and non-woven technologies. Raw materials include polyester, bio-absorbable polymers and metals. | Location Pinebluff | |
Company Baebies Inc. | Activity: Production and Manufacturing | Company Description Baebies is a medical device company that develops and commercializes products to enable early disease detection and comprehensive diagnosis for children and adults. | Location Durham | |
Company Bayer Environmental Science | Activity: Research and Development | Company Description Bayer Environmental Science develops and markets pest-, weed- and disease-control products for non-agricultural areas such as vector control, professional pest management, industrial vegetation management, forestry and turf and ornamentals. | Location Cary | |
Company BioCryst Pharmaceuticals Inc. | Activity: Research and Development | Company Description BioCryst Pharmaceuticals designs and develops novel, small-molecule oral drugs that block key enzymes to treat rare diseases. The Durham location houses BioCryst's clinical, regulatory and executive teams. | Location Durham | |
Company Biomason Inc. | Activity: Research and Development | Company Description Biomason develops cement by using microorganisms fed an aqueous solution, which harden to ASTM specification in ambient temperatures. | Location Durham | |
Company Bioventus LLC | Activity: Research and Development | Company Description Bioventus develops and markets orthobiologic solutions for musculoskeletal healing and regeneration. The Innovations For Active Healing from Bioventus include offerings for osteoarthritis, surgical and non-surgical bone healing. | Location Durham | |
Company Chiesi USA Inc. | Activity: Research and Development | Company Description Chiesi USA, the U.S. affiliate of Chiesi Farmaceutici S.p.A, develops and commercializes products in the therapeutic areas of rare disease, respiratory, cardiovascular, neonatology and cystic fibrosis. | Location Cary | |
Company Cotton Incorporated | Activity: Research and Development | Company Description Cotton Incorporated's Agricultural & Environmental Research Division improves cotton cultivation through genetic and biotechnology tools, enhancing yield, quality and resistance of cotton varieties. | Location Cary | |
Company Eli Lilly and Company (Durham) | Activity: Production and Manufacturing | Company Description Lilly performs drug formulation fill/finishes activities for marketed and late-stage pipeline candidates at its RTP site, with an initial focus on its diabetes products Trulicity and Tirzepatide. | Location Durham | |
Company G1 Therapeutics Inc. | Activity: Research and Development | Company Description G1 Therapeutics is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for those affected by cancer. | Location Research Triangle Park | |
Company GRAIL Inc. | Activity: Contract Research and Testing | Company Description GRAIL develops technologies to detect cancer early. GRAIL’s RTP site includes laboratory and warehouse space to expand the diagnostic testing capabilities of their liquid biopsy-based early-stage oncology test. | Location Durham | |
Company Humacyte Inc. | Activity: Research and Development | Company Description Humacyte develops a technology platform that isolates and grows stable investigational human tissue replacements with potential regenerative medicine, vascular and nonvascular surgery applications. | Location Durham | |
Company Inotiv | Activity: Contract Research and Testing | Company Description Inotiv provides GLP toxicology, histopathology, molecular biology and research and development services to government and commercial clients in agro-chemical, biopharmaceutical and environmental industries. | Location Morrisville | |
Company MED-EL Corporation USA | Activity: Research and Development | Company Description Med-El researches and develops cochlear implant technology. The Durham location manufactures cochlear implants and is also the North American headquarters. | Location Durham | |
Company Medicago USA Inc. | Activity: Research and Development | Company Description Medicago develops vaccines based on proprietary manufacturing technologies and virus-like particles. The vaccines are manufactured using a transient protein expression system in Nicotiana benthamiana, a close relative of tobacco. | Location Durham | |
Company Metabolon Inc. | Activity: Contract Research and Testing | Company Description Metabolon is advancing the science of metabolomics for the clinic and life sciences research. Its technology and data are used for biomarker discovery, diagnostic test development, and genomics and population health initiatives. | Location Morrisville | |
Company Pairwise | Activity: Research and Development | Company Description Pairwise develops new varieties of crops by developing genome editing tools, leveraging plants' natural genetic diversity, and creating partnerships and collaborations with agriculture companies. | Location Durham | |
Company Precision BioSciences Inc. (Durham) | Activity: Research and Development | Company Description Precision BioSciences utilizes a proprietary genome editing method called ARCUS to treat cancers and genetic diseases, and enable the development of safer, more productive food sources. | Location Durham | |
Company Precision Biosciences Manufacturing Center for Advanced Therapeutics (RTP) | Activity: Production and Manufacturing | Company Description Precision BioSciences utilizes a proprietary genome editing method called ARCUS to treat cancers and genetic diseases. The MCAT facility produces genome-edited, off-the-shelf CAR T-cell therapy products. | Location Research Triangle Park | |
Company Resilience (Durham) | Activity: Production and Manufacturing | Company Description National Resilience manufactures lentiviral vectors, a component of cell and gene therapies. | Location Durham | |
Company Roivant Sciences Inc. | Activity: Research and Development | Company Description Roivant Sciences acquires drug candidates or partners with the biopharma industry to complete the clinical development of shelved product candidates. Therapeutic areas include neurology, dermatology, hepatology, oncology, endocrinology and rare disease. | Location Durham | |
Company Sagent Pharmaceuticals | Activity: Production and Manufacturing | Company Description Sagent Pharmaceuticals develops, manufactures, packages and markets pharmaceutical products with an emphasis on injectables. Its Raleigh site produces sterile injectables and lyophilized formulations of biosimilars. | Location Raleigh | |
Company StrideBio Inc. | Activity: Research and Development | Company Description StrideBio develops engineered viral vectors for gene therapy for the treatment of rare diseases. StrideBio's technology engine utilizes structure-inspired design to engineer AAV vectors which can escape pre-existing neutralizing antibodies (NAbs). | Location Research Triangle Park | |
Company Synteract Inc. | Activity: Contract Research and Testing | Company Description Synteract provides customized, full-service phase one through four clinical development services internationally across multiple therapeutic areas. | Location Morrisville | |
Company Tergus Pharma LLC | Activity: Production and Manufacturing | Company Description Tergus Pharma provides contract services for topical pharmaceuticals, including research, drug development, and testing to scale-up and commercial manufacturing. | Location Durham |